Virginia Cancer Specialists (VCS) recently announced that it has been recognized by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) because of its dedication to ensuring patients participate in high-quality clinical trials. Read More »
SPIRE-HR and SPIRE-FH lipid-lowering studies meet primary endpoints. Read More »
Two software programs to integrate and automate medical reviews and payment authorizations. Read More »
Forcing drug companies to disclose wholesale prices would likely put more pressure on consumers’ wallets, health economist Devon Herrick said. Read More »
In keeping with President Obama's budget request, a Senate committee recently approved a request to create a small fee for the 340B drug discount program. Read More »
Pfizer Inc. recently announced its completed acquisition of Anacor Pharmaceuticals, Inc., giving each outstanding Anacor common stock share the opportunity to gain $99.25 net in cash as part of the acquisition. Read More »
The Pfizer Get Old community and Idiegogo's entrepreneurs invited to submit products or services that support healthy aging. Read More »
Pfizer recently announced that several studies and analyses for its tofacitinib citrate (XELJANZ) treatment for rheumatoid arthritis (RA) will be featured at the European League Against Rheumatism Annual Congress (EULAR 2016). Read More »
The U.S. Food and Drug Administration’s (FDA) Advisory Committees has recommended extended-release capsules for ALO-02 from Pfizer. Read More »
McKesson detailed the occurrences of prescription abandonment tied to financial motivations in a recent article. Read More »
Pfizer announced last week that Jim Furyk has joined the company in advocating awareness for older individuals at risk for infectious diseases, including pneumococcal pneumonia. Read More »
"Know Your Cataract EYE-Q" campaign launched to educate consumers about cataracts and their treatment. Read More »
The interactive forum brings independent pharmacists together to collaborate on ways to expand business, improve profits and help their patients. Read More »
New safety and efficiency data included on labels after EAGLES clinical trial. Read More »
Fourteen presentations will present results of avelumab treatments for seven different cancer types. Read More »
Pfizer will showcase its growing portfolio of innovative treatments for a variety of cancers. Read More »
Communication key to developing treatment goals and disease management plan. Read More »
McKesson's ClaimsXten and ClaimsXten Select will integrate with TriZetto's QNXT to simplify claims management. Read More »
Agreement combines pharmaceutical industry expertise with a commitment to low prices. Read More »
Pfizer will acquire crisaborole, a treatment for eczema, in the deal. Read More »
Alerts Sign-up
